LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ph Ib/BGJ398/Cervix and Other Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin in Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
- Status
- TERMINATED
- Phase
- PHASE4
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
- Status
- COMPLETED
- Phase
- PHASE3
First in Human Study of M4344 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers
- Status
- COMPLETED
- Phase
- PHASE3